documents: FDA-2016-D-4308-0012
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2016-D-4308-0012 | FDA | FDA-2016-D-4308 | 10 Reference 9 FDA Guidance for Industry For the Submission of Chemistry Manufacturing and Controls and Establishment Description Information for Human Blood and Blood Components Intended for Transfusion re Labeling of Red Blood Cell Units with Historical Antigen Typing Results Draft Guidance for Industry | Supporting & Related Material | Background Material | 2017-01-03T05:00:00Z | 2017 | 1 | 2017-01-03T15:14:09Z | 0 | 0 | 0900006482446f1f |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref